Acute intracerebral hemorrhage in intravascular lymphoma - A serious infusion related adverse event of rituximab

被引：8

作者：

Ganguly, Siddhartha ^{[1
]}

机构：

[1] Univ Kansas, Med Ctr, Div Hematol, Kansas City, KS 66103 USA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2007年 / 30卷 / 02期

关键词：

intravascular lymphoma; angiotropic lymphoma; Rituximab; CNS lymphoma;

D O I：

10.1097/01.coc.0000182463.57861.3c

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：211 / 212

页数：2

共 4 条

[1] Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects and rapid blood tumor clearance [J].

Byrd, JC ;

Waselenko, JK ;

Maneatis, TJ ;

Murphy, T ;

Ward, FT ;

Monahan, BP ;

Sipe, MA ;

Donegan, S ;

White, CA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :791-795

[2] Intravascular lymphoma presenting with cauda equina syndrome: Treated with CHOP and rituxan [J].

Davis, TS .

LEUKEMIA & LYMPHOMA, 2003, 44 (05) :887-888

[3]

Han K, 2003, CUTIS, V72, P137

[4] Lack of CD 29 (β1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis [J].

Ponzoni, M ;

Arrigoni, G ;

Gould, VE ;

Del Curto, B ;

Maggioni, M ;

Scapinello, A ;

Paolino, S ;

Cassisa, A ;

Patriarca, C .

HUMAN PATHOLOGY, 2000, 31 (02) :220-226

← 1 →